TOT Biopharm International Co (HKSE:01875) Other Stockholders Equity : HK$84 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is TOT Biopharm International Co Other Stockholders Equity?

TOT Biopharm International Co's Other Stockholders Equity for the quarter that ended in Jun. 2024 was HK$84 Mil.

TOT Biopharm International Co's quarterly Other Stockholders Equity increased from Jun. 2023 (HK$78 Mil) to Dec. 2023 (HK$79 Mil) and increased from Dec. 2023 (HK$79 Mil) to Jun. 2024 (HK$84 Mil).

TOT Biopharm International Co's annual Other Stockholders Equity increased from Dec. 2021 (HK$46 Mil) to Dec. 2022 (HK$69 Mil) and increased from Dec. 2022 (HK$69 Mil) to Dec. 2023 (HK$79 Mil).

TOT Biopharm International Co Other Stockholders Equity Historical Data

The historical data trend for TOT Biopharm International Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOT Biopharm International Co Other Stockholders Equity Chart

TOT Biopharm International Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

41.09

58.68

46.28

69.14

79.27

TOT Biopharm International Co Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Stockholders Equity	Get a 7-Day Free Trial								54.62	69.14	77.92	79.27	84.09

TOT Biopharm International Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

TOT Biopharm International Co Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of TOT Biopharm International Co's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

TOT Biopharm International Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TOT Biopharm International Co Ltd (HKSE:01875) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Changyang Street, Suzhou Industrial Park, Suzhou, CHN, 215024

Website

https://www.totbiopharm.com.cn

TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families as well as medical professionals. It has a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). It generates revenues from Mainland China.

Executives

Center Laboratories, Inc.	2201 Interest of corporation controlled by you
Tricor Trust (hong Kong) Limited	2301 Trustee
Chengwei Evergreen Capital, Lp	2101 Beneficial owner
Center Laboratories Inc.	2101 Beneficial owner
Chengwei Evergreen Management, Llc	2201 Interest of corporation controlled by you
Suzhou Vivo Management Consulting Partnership (limited Partnership)
Vivo (suzhou) Health Industry Investment Fund (limited Partnership)
Vivo Capital Llc
Vivo Capital Viii, Llc
Vivo Capital Fund Viii, L.p.
Prime Success International Limited	2101 Beneficial owner
Advantech Capital Ii L.p.
Advantech Capital Ii Master Investment Limited
Advantech Capital Investment V Limited
Advantech Capital Partners Ii Limited

TOT Biopharm International Co Headlines

No Headlines